Details about the neuroanatomical projections from ORBvl to ENTl
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91807 | Orbital area ventrolateral part | Entorhinal area, lateral part | light/moderate | biotinylated dextran amine (BDA) | In EC, labeled axons, passing through the deep layers of LEC (Fig. 5A–D), terminated in the upper layers of the caudal portion of the dorsal lateral LEC (Figs. 5E, 12C), and caudally adjacent caudal part of MEC (Figs. 5F, 12E). Collator note: weak-moderate labeling of the caudalmost portions of the ENTl and ENTm, respectively. The labeled terminals are located in layers II-III. See Fig. 5E-F, Swanson Atlas Levels 45-47. | Kondo H. & Witter M.P., 2014 | |
| 91826 | Orbital area ventrolateral part | Entorhinal area, lateral part | light | biotinylated dextran amine (BDA) | Collator note: field with terminals and fibers of passage restricted to the dorsal part of the central ENTl. See Fig. 6D, Swanson Atlas Levels 41-42. | Kondo H. & Witter M.P., 2014 | |
| 91827 | Orbital area ventrolateral part | Entorhinal area, lateral part | moderate | biotinylated dextran amine (BDA) | Collator note: terminal field in the caudal ENTl, with some fibers in the ventral ENTm. See Fig 6E, Swanson Atlas Levels 45-46. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-17), the BDA injection targeted the lateral portion of VO at a caudal level (Figs. 2, 5). The injection involved mainly layers II and III.Collator note: injection in the caudal third of the ORBvl. See Figs. 1, 2, and 5. The injection is mapped here onto Swanson Atlas Levels 5-6. |
Further details associated to record number 91826:
|
|
|---|
